Evidence map›Paper›PMID 40127071›Full record

ArticlePloS one2025

Brain tumor intelligent diagnosis based on Auto-Encoder and U-Net feature extraction.

Yaru Cao, Fengning Liang, Teng Zhao, Jinting Han, Yingchao Wang, Haowen Wu, Kexing Zhang, Huiwen Qiu, Yizhe Ding, Hong Zhu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yaru CaoSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Fengning LiangSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Teng ZhaoSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Jinting HanSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yingchao WangSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Haowen WuSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Kexing ZhangSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Huiwen QiuSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yizhe DingSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Hong ZhuSchool of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID 0000-0002-1676-940X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative classification of brain tumors is critical to developing personalized treatment plans, however existing classification methods rely on manual intervention and often have problems with efficiency and accuracy, which may lead to misdiagnosis or delayed diagnosis in clinical practice and affect the therapeutic effect. We propose a fully automated approach to brain tumor magnetic resonance imaging (MRI) classification, consisted by a feature extractor based on the improved U-Net and a classifier based on convolutional recurrent neural network (CRNN). The encoder of the feature extractor based on dense block, is used to enhance feature propagation and reduce the number of parameters. The decoder uses residual block to reduce the weight of some features for improving the effect of MRI spatial sequence reconstruction, and avoid gradient disappearance. Skip connections between the encoder and the decoder effectively merge low-level features and high-level features. The extract feature sequence is input into the CRNN-based classifier for final classification. We assessed the performance of our method for grading glioma, glioma isocitrate dehydrogenase1 (IDH1) mutation status classification and pituitary tumor texture classification on two datasets, glioma or pituitary tumors collected in a local affiliated hospital and glioma imaging data from TCIA. Compared with commonly models and new models, our model achieves higher accuracy, with an accuracy of 90.72%, classified glioma IDH1 mutation status with an accuracy of 94.35%, and classified pituitary tumor texture with an accuracy of 94.64%.

Indexed as

Brain NeoplasmsGliomaNeural Networks, ComputerAlgorithmsHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMutationPituitary NeoplasmsIDH1 protein, humanIsocitrate Dehydrogenase

Identifiers

PMID40127071
PMCPMC11932485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.